Weight Regain Risks
2 articles on Weight Regain Risks, written by Shotlee and medically reviewed for clinical accuracy.
Quitting GLP-1s Like Ozempic? Many Plan to Restart Despite Risks
Many patients start GLP-1 medications like Ozempic and Zepbound for obesity but quit within a year, with fewer than one in four remaining on treatment. Shockingly, 74% of those who stop plan to restart, despite experts warning against this cycling approach. This guide explores the data, risks like muscle loss, and what it means for your health.
5 min read
GLP-1 Long-Term Use: Regain Risks, Costs & Alternatives
GLP-1 medications like Ozempic and Wegovy promise dramatic weight loss, but new studies reveal a catch: most users regain weight within 1-2 years of stopping. High costs and side effects add to the burden, prompting interest in permanent alternatives. Learn the facts to make informed choices for your metabolic health.
4 min read